title: DNAVaxDB: the first web-based DNA vaccine database and its data analysis.
abstract: Since the first DNA vaccine studies were done in the 1990s, thousands more studies have followed. Here we report the development and analysis of DNAVaxDB (http://www.violinet.org/dnavaxdb), the first publically available web-based DNA vaccine database that curates, stores, and analyzes experimentally verified DNA vaccines, DNA vaccine plasmid vectors, and protective antigens used in DNA vaccines. All data in DNAVaxDB are annotated from reliable resources, particularly peer-reviewed articles. Among over 140 DNA vaccine plasmids, some plasmids were more frequently used in one type of pathogen than others; for example, pCMVi-UB for G- bacterial DNA vaccines, and pCAGGS for viral DNA vaccines. Presently, over 400 DNA vaccines containing over 370 protective antigens from over 90 infectious and non-infectious diseases have been curated in DNAVaxDB. While extracellular and bacterial cell surface proteins and adhesin proteins were frequently used for DNA vaccine development, the majority of protective antigens used in Chlamydophila DNA vaccines are localized to the inner portion of the cell. The DNA vaccine priming, other vaccine boosting vaccination regimen has been widely used to induce protection against infection of different pathogens such as HIV. Parasitic and cancer DNA vaccines were also systematically analyzed. User-friendly web query and visualization interfaces are available in DNAVaxDB for interactive data search. To support data exchange, the information of DNA vaccines, plasmids, and protective antigens is stored in the Vaccine Ontology (VO). DNAVaxDB is targeted to become a timely and vital source of DNA vaccines and related data and facilitate advanced DNA vaccine research and development.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Racz
authors.forename: Xinna
authors.initials: X
authors.lastname: Li
authors.forename: Mukti
authors.initials: M
authors.lastname: Patel
authors.forename: Zuoshuang
authors.initials: Z
authors.lastname: Xiang
authors.forename: Yongqun
authors.initials: Y
authors.lastname: He
mesh_terms: D000942:Antigens, Bacterial / Q000276:immunology; D001419:Bacteria / Q000276:immunology; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D030561:Databases, Nucleic Acid / Q000706:statistics & numerical data; D006801:Humans; D020407:Internet; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control; D011506:Proteins / Q000276:immunology; D012984:Software; D019444:Vaccines, DNA / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology / Q000517:prevention & control; D014780:Viruses / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D019496:Cancer Vaccines; D011506:Proteins; D019444:Vaccines, DNA; D014765:Viral Vaccines
references.citation: J Biomed Semantics. 2012 Dec 20;3(1):17
references.pmid: 23256535
references.citation: BMC Bioinformatics. 2013;14 Suppl 4:S2
references.pmid: 23514126
references.citation: J Gene Med. 2005 Jan;7(1):3-17
references.pmid: 15538731
references.citation: Gene Ther. 2005 Jul;12(13):1049-57
references.pmid: 15800663
references.citation: J Biomed Biotechnol. 2010;2010:218590
references.pmid: 21772787
references.citation: J Biomed Semantics. 2011 May 17;2 Suppl 2:S8
references.pmid: 21624163
references.citation: Vet Microbiol. 2002 Sep 2;88(3):205-21
references.pmid: 12151196
references.citation: J Intern Med. 2003 Apr;253(4):402-10
references.pmid: 12653868
references.citation: Vaccine. 2005 Apr 27;23(23):3016-25
references.pmid: 15811648
references.citation: Biotechnol Adv. 2009 Jul-Aug;27(4):353-70
references.pmid: 19233255
references.citation: Vaccine. 2006 May 22;24(21):4582-5
references.pmid: 16188351
references.citation: BMC Bioinformatics. 2006 Jul 16;7:347
references.pmid: 16842628
references.citation: Microbes Infect. 2005 May;7(5-6):962-7
references.pmid: 15890555
references.citation: Viral Immunol. 2013 Feb;26(1):68-74
references.pmid: 23330678
references.citation: J Mol Biol. 2011 Jul 22;410(4):582-608
references.pmid: 21762802
references.citation: Vaccine. 2008 Feb 26;26(9):1195-203
references.pmid: 18243431
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D923-8
references.pmid: 18025042
references.citation: Vaccine. 2007 Jan 2;25(1):43-54
references.pmid: 17049676
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D52-7
references.pmid: 21115458
references.citation: Curr Opin Virol. 2011 Oct;1(4):233-40
references.pmid: 22440782
references.citation: Nucleic Acids Res. 2014 Jan;42(Database issue):D1124-32
references.pmid: 24259431
references.citation: Science. 1990 Mar 23;247(4949 Pt 1):1465-8
references.pmid: 1690918
references.citation: BMC Res Notes. 2010 Jun 22;3:175
references.pmid: 20569493
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D1073-8
references.pmid: 20959289
references.citation: Virology. 1998 Nov 10;251(1):1-15
references.pmid: 9813197
references.citation: Hum Vaccin. 2010 Jan;6(1):78-83
references.pmid: 20061802
references.citation: Vaccine. 2011 Feb 4;29(7):1455-62
references.pmid: 21185849
references.citation: J Biomed Biotechnol. 2010;2010:297505
references.pmid: 20671958
references.citation: J Pain Palliat Care Pharmacother. 2008;22(1):45-46
references.pmid: 28792816
references.citation: Curr Opin Biotechnol. 2007 Dec;18(6):546-56
references.pmid: 18063357
references.citation: Vaccine. 2013 Jan 21;31(5):797-805
references.pmid: 23219434
references.citation: Emerg Infect Dis. 2007 Mar;13(3):426-35
references.pmid: 17552096
references.citation: Hum Vaccin. 2008 Nov-Dec;4(6):449-52
references.pmid: 18443427
references.citation: J Virol. 2009 Jun;83(11):5947-50
references.pmid: 19321619